StemCells, Inc. , a leading stem cell company developing novel cell-based therapeutics for disorders of the central nervous system, posted today the following Letter to Shareholders from its President and CEO, Martin McGlynn. Over the past year, StemCells, Inc. has made substantial progress.
http://ift.tt/1JtfmTB
http://ift.tt/1JtfmTB
No comments:
Post a Comment